Clinical evaluation of autonomous, unsupervised planning integrated in MR-guided radiotherapy for prostate cancer.

Autor: Künzel LA; Section for Biomedical Physic, Department of Radiation Oncology, University Hospital Tübingen, Germany., Nachbar M; Section for Biomedical Physic, Department of Radiation Oncology, University Hospital Tübingen, Germany., Hagmüller M; Section for Biomedical Physic, Department of Radiation Oncology, University Hospital Tübingen, Germany., Gani C; Department of Radiation Oncology, University Hospital Tübingen, Germany., Boeke S; Department of Radiation Oncology, University Hospital Tübingen, Germany., Wegener D; Department of Radiation Oncology, University Hospital Tübingen, Germany., Paulsen F; Department of Radiation Oncology, University Hospital Tübingen, Germany., Zips D; Department of Radiation Oncology, University Hospital Tübingen, Germany; German Cancer Consortium (DKTK), partner site Tübingen, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Thorwarth D; Section for Biomedical Physic, Department of Radiation Oncology, University Hospital Tübingen, Germany; German Cancer Consortium (DKTK), partner site Tübingen, and German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: Daniela.thorwarth@med.uni-tuebingen.de.
Jazyk: angličtina
Zdroj: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2022 Mar; Vol. 168, pp. 229-233. Date of Electronic Publication: 2022 Feb 05.
DOI: 10.1016/j.radonc.2022.01.036
Abstrakt: This retrospective study aimed at clinical evaluation of autonomous radiotherapy planning for ten prostate cancer cases, including organ-at-risk/target contouring and treatment planning. Five experts scored the clinical acceptability of each step using a 4-level Likert-scale resulting in 78%, 66% and 90% acceptance. For 6/10 patients the entire workflow was considered acceptable.
Competing Interests: Conflicts of interest The Department of Radiation Oncology Tübingen receives within the frame of research agreements financial and technical support as well as sponsoring for travels and scientific symposia from Elekta AB (Stockholm, Sweden), TheraPanacea (Paris, France), Philips GmbH (Best, The Netherlands); Dr. Sennewald Medizintechnik GmbH (München, Germany), PTW Freiburg (Germany).
(Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: